Two eye treatments for serious diabetic eye condition – final draft guidance NICE recommended aflibercept solution for injection (Eylea, Bayer Pharma), and dexamethasone intravitreal(i) implant (Ozurdex, Allergan) as possible treatment options for some people with diabetic macular oedema, in two separate pieces of final draft guidance published (2 June). This oedema is a common complication…
UK: Dexamethasone treatment for diabetic eye condition
Dexamethasone treatment of common diabetic eye condition. NICE is recommending dexamethasone (Ozurdex, Allergan) intravitreal(1) implant, for the treatment of diabetic macular oedema (DMO) in preliminary recommendations published 20/02/ 2015. The draft guidance recommends dexamethasone as a treatment option in people only where: the implant is to be used in an eye with an intraocular (pseudophakic)(2)…